| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |